BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28008925)

  • 1. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection.
    Eletto D; Burns SO; Angulo I; Plagnol V; Gilmour KC; Henriquez F; Curtis J; Gaspar M; Nowak K; Daza-Cajigal V; Kumararatne D; Doffinger R; Thrasher AJ; Nejentsev S
    Nat Commun; 2016 Dec; 7():13992. PubMed ID: 28008925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.
    Daza-Cajigal V; Albuquerque AS; Young DF; Ciancanelli MJ; Moulding D; Angulo I; Jeanne-Julien V; Rosain J; Minskaia E; Casanova JL; Boisson-Dupuis S; Bustamante J; Randall RE; McHugh TD; Thrasher AJ; Burns SO
    Front Immunol; 2022; 13():888427. PubMed ID: 36159783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
    Kohlhuber F; Rogers NC; Watling D; Feng J; Guschin D; Briscoe J; Witthuhn BA; Kotenko SV; Pestka S; Stark GR; Ihle JN; Kerr IM
    Mol Cell Biol; 1997 Feb; 17(2):695-706. PubMed ID: 9001223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel STAT1 alleles in a patient with impaired resistance to mycobacteria.
    Kristensen IA; Veirum JE; Møller BK; Christiansen M
    J Clin Immunol; 2011 Apr; 31(2):265-71. PubMed ID: 21057861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-γ.
    Gordon GM; Lambert QT; Daniel KG; Reuther GW
    Biochem J; 2010 Dec; 432(2):255-65. PubMed ID: 20868368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus.
    Shi L; Ramaswamy M; Manzel LJ; Look DC
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):720-8. PubMed ID: 17641294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
    Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
    J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of three JAK-STAT pathway genes in feather follicle development during chicken embryogenesis.
    Tao Y; Zhou X; Liu Z; Zhang X; Nie Y; Zheng X; Li S; Hu X; Yang G; Zhao Q; Mou C
    Gene Expr Patterns; 2020 Jan; 35():119078. PubMed ID: 31759166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
    Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S
    J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.
    Chapgier A; Boisson-Dupuis S; Jouanguy E; Vogt G; Feinberg J; Prochnicka-Chalufour A; Casrouge A; Yang K; Soudais C; Fieschi C; Santos OF; Bustamante J; Picard C; de Beaucoudrey L; Emile JF; Arkwright PD; Schreiber RD; Rolinck-Werninghaus C; Rösen-Wolff A; Magdorf K; Roesler J; Casanova JL
    PLoS Genet; 2006 Aug; 2(8):e131. PubMed ID: 16934001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Janus kinase/signal transducer and activator of transcription pathway in multiple myeloma is not related to point mutations in kinase and pseudokinase domains of JAK1.
    Corbi FC; de Oliveira MB; Morelli VM; Han SW; Renauld JC; Knoops L; Colleoni GW
    Leuk Lymphoma; 2014 May; 55(5):1176-80. PubMed ID: 23885837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.
    Yang CH; Murti A; Valentine WJ; Du Z; Pfeffer LM
    J Biol Chem; 2005 Jul; 280(27):25849-53. PubMed ID: 15883164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
    Müller M; Briscoe J; Laxton C; Guschin D; Ziemiecki A; Silvennoinen O; Harpur AG; Barbieri G; Witthuhn BA; Schindler C
    Nature; 1993 Nov; 366(6451):129-35. PubMed ID: 8232552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation.
    Haan S; Margue C; Engrand A; Rolvering C; Schmitz-Van de Leur H; Heinrich PC; Behrmann I; Haan C
    J Immunol; 2008 Jan; 180(2):998-1007. PubMed ID: 18178840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
    Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
    EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations.
    Ren Y; Zhang Y; Liu RZ; Fenstermacher DA; Wright KL; Teer JK; Wu J
    Sci Rep; 2013 Oct; 3():3042. PubMed ID: 24154688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma in NFS-60 cells.
    Novak U; Ward AC; Hertzog PJ; Hamilton JA; Paradiso L
    Growth Factors; 1996; 13(3-4):251-60. PubMed ID: 8919032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.
    Flex E; Petrangeli V; Stella L; Chiaretti S; Hornakova T; Knoops L; Ariola C; Fodale V; Clappier E; Paoloni F; Martinelli S; Fragale A; Sanchez M; Tavolaro S; Messina M; Cazzaniga G; Camera A; Pizzolo G; Tornesello A; Vignetti M; Battistini A; Cavé H; Gelb BD; Renauld JC; Biondi A; Constantinescu SN; Foà R; Tartaglia M
    J Exp Med; 2008 Apr; 205(4):751-8. PubMed ID: 18362173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.